StonvexLoading…
StonvexStonvexStonvexCore line items from CUZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $264.90M | $263.11M | $993.82M | $738.78M | $490.46M |
Operating Income | Not available | $180.06M | $673.31M | $501.11M | $331.93M |
Net Income | Not available | $-24.86M | $40.50M | $43.97M | $35.38M |
EPS (Diluted) | $0.06 | $-0.15 | $0.24 | $0.26 | $0.21 |
Total Assets | Not available | $9.09B | $8.89B | $8.90B | $9.05B |
Total Liabilities | Not available | $4.55B | $4.19B | $4.14B | $4.25B |
Cash & Equivalents | Not available | $6.30M | $5.72M | $4.67M | $416.84M |
Free Cash Flow OCF − CapEx | Not available | Not available | $135.04M | Not available | Not available |
Shares Outstanding | Not available | 164.54M | 167.98M | 167.97M | 168.68M |